Get started
Author

Maria V. Balovneva

Observed names: M V Balovneva, M. V Balovneva, M. V. Balovneva, M.V. Balovneva, Maria Balovneva, Mariya V. Balovneva, Баловнева М.В., Баловнева Мария Владимировна, М В Баловнева, М. V. Balovneva, М. В. Баловнева
ORCID: 0000-0003-2198-7521
Observed ORCID: 0000-0003-2198-7521
OpenAlex ID: A5015660997
Pre-Clinical Studies of Inactivated Polyvalent HFRS Vaccine
2020 · Tamara K. Dzagurova, Alexandra A. Siniugina, et al. · Frontiers in Cellular and Infection Microbiology · 23
PDF
Severe hantavirus disease in children
2018 · Tamara K. Dzagurova, Evgeniy A. Tkachenko, et al. · Journal of Clinical Virology · 16
Various Adjuvants Effect on Immunogenicity of Puumala Virus Vaccine
2020 · Svetlana S. Kurashova, Aidar A. Ishmukhametov, et al. · Frontiers in Cellular and Infection Microbiology · 15
PDF
A fatal case of haemorrhagic fever with renal syndrome in Kursk Region, Russia, caused by a novel Puumala virus clade
2022 · Ekaterina Blinova, Andrei Deviatkin, et al. · Infection Genetics and Evolution · 12
PDF
Expression system for Yarrowia lipolytica based on a promoter of the mitochondrial potential-dependent porin VDAC gene
2016 · Ekaterina Yu Epova, Maria V. Balovneva, et al. · Biotechnology and Bioprocess Engineering · 10
Pre-Clinical Studies of Inactivated Polivalent Vaccine Against Hemorrhagic Fever with Renal Syndrome
2019 · A. A. Sinyugina, T. K. Dzagurova, et al. · Epidemiology and Vaccinal Prevention · 7
PDF
Effect of Virus-Inactivating Agents on the Immunogenicity of Hantavirus Vaccines against Hemorrhagic Fever with Renal Syndrome
2020 · M. S. Egorova, S. S. Kurashova, et al. · Applied Biochemistry and Microbiology · 5
Comparative Characteristics of Inactivation Agents for HFRS Vaccine Development
2018 · C. C. Kurashova, A. A. Ishmukhametov, et al. · Epidemiology and Vaccinal Prevention · 5
PDF
Carbohydrate-Based Adjuvants for Vaccine Production
2018 · S. S. Kurashova, T. K. Dzagurova, et al. · Biological Products Prevention Diagnosis Treatment · 5
PDF
Immune response evaluation in the guinea pigs after immunization with the experimental Puumala virus vaccine
2022 · S. S. Kurashova, M. V. Balovneva, et al. · Russian Journal of Infection and Immunity · 4
PDF
Real-time PCR assay development for the control of vaccine against hemorrhagic fever with renal syndrome
2021 · M. S. Egorova, S. S. Kurashova, et al. · Problems of Virology · 4
PDF
Hemorrhagic Fever With Renal Syndrome Group Outbreak Caused by Sochi Virus
2019 · T. K. Dzagurova, A. A. Ishmukhametov, et al. · Problems of Virology · 4
PDF
Characteristics of Hantaviruses as Causative Agents of the Zoonotic Hemorrhagic Fevers
2017 · A. A. Ishmukhametov, T. K. Dzagurova, et al. · Epidemiology and Vaccinal Prevention · 4
PDF
Physical and Chemical Inactivators Evaluation for the Puumala Virus Vaccine Technology Development
2024 · S. S. Kurashova, M. S. Egorova, et al. · Epidemiology and Vaccinal Prevention · 3
PDF
[Development of ELISA on the basis of monoclonal antibodies for detecting specific activity of the vaccine against hemorrhagic fever with renal syndrome].
2013 · T K Dzagurova, O N Solopova, et al. · PubMed · 3
The effect of carbohydrate adjuvants in the composition of the experimental hantavirus vaccine on the dynamics of neutralizing antibodies in the blood sera of guinea pigs
2024 · Svetlana S. Kurashova, Maria S. Egorova, et al. · Journal of microbiology epidemiology immunobiology · 2
Urine excreted antibodies significance in the hemorrhagic fever with renal syndrome specific diagnosis
2022 · T. K. Dzagurova, R. T. Murzabaeva, et al. · Russian Journal of Infection and Immunity · 2
PDF
Vaccines for Prevention of Hantaviral Fevers
2019 · A. A. Sinyugina, A. A. Ishmukhametov, et al. · Epidemiology and Vaccinal Prevention · 2
PDF
The Effect of Adjuvants of Different Groups on the Immunogenicity of Vaccines against Hemorrhagic Fever with Renal Syndrome
2020 · Т.К. Dzagurova, M.S. Egorova, et al. · Biotekhnologiya · 1
Effect of Virus Inactivating Agents on the Immunogenicity of Hantavirus Vaccines against Hemorrhagic Fever with Renal Syndrome
2020 · S.S. Kurashova, Т.К. Dzagurova, et al. · Biotekhnologiya · 1
Vaccines for the prevention of hantavirus fevers: An overview of results and development prospects
2026 · R. D. Teodorovich, T. K. Dzagurova, et al. · Biological Products Prevention Diagnosis Treatment
PDF
Features of the replication of hantaviruses - pathogens of hemorrhagic fever with renal syndrome in cell cultures of different origin
2014 · G. A Malkin, T. K Dzagurova, et al. · Epidemiology and Infectious Diseases
PDF
Методы предсказания сайтов посттрансляционной модификации при образовании липопротеинов
2013 · Е С Маракасова, Е И Ярыгина, et al. · CyberLeninK (CyberLeninka)
Изучение эффективности пероральной доставки соматолиберина в составе биомассы рекомбинантных штаммов E. coli
2011 · Е. Ю. Эпова, М. С. Смирнова, et al. · Международный журнал экспериментального образования
Современное состояние проблемы геморрагической лихорадки с почечным синдромом в России
2011 · Е. А. Ткаченко, Т К Дзагурова, et al. · CyberLeninK (CyberLeninka)
Works count: 30
Citation count: 128
H-index: 6
I10-index: 5
Year
Topic
Type